Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: A review

Molecules

Volumn 21, Issue 3, 2016, Pages

  Calixto, Giovana Maria Fioramonti ^a   Bernegossi, Jéssica ^a   De Freitas, Laura Marise ^a   Fontana, Carla Raquel ^a   Chorilli, Marlus ^a   Grumezescu, Alexandru Mihai ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE

Author keywords

Cancer; Drug delivery systems; Nanotechnology; Photodynamic therapy

Indexed keywords

HYDROGEL; LIPOSOME; NANOPARTICLE; PHOTOSENSITIZING AGENT;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; LIQUID CRYSTAL; NANOTECHNOLOGY; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; LIPOSOMES; LIQUID CRYSTALS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84963679480     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21030342     Document Type: Review

References (123)

1. Spikes, J.D. The historical development of ideas on applications of photosensitized reactions in the health sciences. In Primary Photo-Processes in Biology and Medicine; Bensasson, R.V., Jori, G., Land, E.J., Truscott, T.G., eds.; Springer: Boston, MA, USA, 1985; pp. 209-227.
2. Rabb, O. Über die wirkung fluoreszierender stoffe auf infusoren. Z. Biol. 1900, 39, 524-526.
3. Von Tappeiner, H.; Jesionek, A. Therapeutische versuche mit fluoreszierenden stoffen. Münch. Med. Wochenschr. 1903, 47, 2042-2044.
4. Mroz, P.; Hashmi, J.T.; Huang, Y.-Y.; Lange, N.; Hamblin, M.R. Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev. Clin. Immunol. 2011, 7, 75-91.
5. Lim, M.E.; Lee, Y.-L.; Zhang, Y.; Chu, J.J.H. Photodynamic inactivation of viruses using upconversion nanoparticles. Biomaterials 2012, 33, 1912-1920.
6. Kharkwal, G.B.; Sharma, S.K.; Huang, Y.-Y.; Dai, T.; Hamblin, M.R. Photodynamic therapy for infections: Clinical applications. Lasers Surg. Med. 2011, 43, 755-767.
7. Ribeiro, M.S.; da Silva, D.d.F.T.; Cristina Nunez, S.; Zezell, M.D. Laser em baixa intensidade. In Técnicas e Procedimentos Terapêuticos; Quintessense editora: São Paulo, SP, Brazil, 2004; pp. 945-953.
8. Dolmans, D.E.J.G.J.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
9. Machado, A.E.d.H. Terapia fotodinâmica: Princípios, potencial de aplicação e perspectivas. Quim. Nova 2000, 23, 237-243.
10. Macdonald, I.J.; Dougherty, T.J. Basic principles of photodynamic therapy. J. Porphyr. Phthalocyanines 2001, 5, 105-129.
11. Allison, R.R.; Moghissi, K. Photodynamic therapy (pdt): Pdt mechanisms. Clin. Endosc. 2013, 46, 24-29.
12. Epstein, J.H. Phototoxicity and photoallergy. Semin. Cutan. Med. Surg. 1999, 18, 274-284.
13. Shah, P.M.; Gerdes, H. Endoscopic options for early stage esophageal cancer. J. Gastrointest. Oncol. 2014, 6, 20-30.
14. Nanashima, A.; Nagayasu, T. Current status of photodynamic therapy in digestive tract carcinoma in Japan. Int. J. Mol. Sci. 2015, 16, 3434-3440.
15. Yano, T.; Muto, M.; Yoshimura, K.; Niimi, M.; Ezoe, Y.; Yoda, Y.; Yamamoto, Y.; Nishisaki, H.; Higashino, K.; Iishi, H. Phase i study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiat. Oncol. 2012, 7.
16. Yano, T.; Muto, M.; Minashi, K.; Iwasaki, J.; Kojima, T.; Fuse, N.; Doi, T.; Kaneko, K.; Ohtsu, A. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: A phase ii study. Int. J. Cancer 2012, 131, 1228-1234.
17. Green, B.; Cobb, A.R.M.; Hopper, C. Photodynamic therapy in the management of lesions of the head and neck. Br. J. Oral Maxillofac. Surg. 2013, 51, 283-287.
18. Simone, C.B., II; Cengel, K.A. Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin. Oncol. 2014, 41, 820-830.
19. Allison, R.R.; Moghissi, K. Oncologic photodynamic therapy: Clinical strategies that modulate mechanisms of action. Photodiagn. Photodyn. Ther. 2013, 10, 331-341.
20. Yoon, I.; Li, J.Z.; Shim, Y.K. Advance in photosensitizers and light delivery for photodynamic therapy. Clin. Endosc. 2013, 46, 7-23.
21. Szaciłowski, K.; Macyk, W.; Drzewiecka-Matuszek, A.; Brindell, M.; Stochel, G. Bioinorganic photochemistry: Frontiers and mechanisms. Chem. Rev. 2005, 105, 2647-2694.
22. Baran, T.M.; Foster, T.H. Comparison of flat cleaved and cylindrical diffusing fibers as treatment sources for interstitial photodynamic therapy. Med. Phys. 2014, 41.
23. Casas, A.; Venosa, G.D.; Hasan, T.; Al, B. Mechanisms of resistance to photodynamic therapy. Curr. Med. Chem. 2011, 18, 2486-2515.
24. Zuluaga, M.F.; Lange, N. Combination of photodynamic therapy with anti-cancer agents. Curr. Med. Chem. 2008, 15, 1655-1673.
25. Ge, R.; Ahn, J.-C.; Shin, J.-I.; Bahk, C.W.; He, P.; Chung, P.-S. An in vitro and in vivo study of combination therapy with photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (ct-26). Photomed. Laser Surg. 2010, 29, 155-160.
26. Kawazoe, K.; Isomoto, H.; Yamaguchi, N.; Inoue, N.; Uehara, R.; Matsushima, K.; Ichikawa, T.; Takeshima, F.; Nonaka, T.; Nanashima, A.; et al. Effects of photodynamic therapy for superficial esophageal squamous cell carcinoma in vivo and in vitro. Oncol. Lett. 2010, 1, 877-882.
27. O'Connor, A.E.; Gallagher, W.M.; Byrne, A.T. Porphyrin and nonporphyrin photosensitizers in oncology: Preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol. 2009, 85, 1053-1074.
28. Brown, S.B.; Brown, E.A.; Walker, I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004, 5, 497-508.
29. Dai, T.; Huang, Y.-Y.; Hamblin, M.R. Photodynamic therapy for localized infections-State of the art. Photodiagn. Photodyn. Ther. 2009, 6, 170-188.
30. Dougherty, T.J.; Marcus, S.L. Photodynamic therapy. Eur. J. Cancer 1992, 28, 1734-1742.
31. Jockusch, S.; Lee, D.; Turro, N.J.; Leonard, E.F. Photo-induced inactivation of viruses: Adsorption of methylene blue, thionine, and thiopyronine on qbeta bacteriophage. Proc. Natl. Acad. Sci. USA 1996, 93, 7446-7451.
32. Phoenix, D.A.; Harris, F. Phenothiazinium-based photosensitizers: Antibacterials of the future? Trends Mol. Med. 2003, 9, 283-285.
33. Harris, F.; Chatfield, L.K.; Phoenix, D.A. Phenothiazinium based photosensitisers-Photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug Targets 2005, 6, 615-627.
34. Tuite, E.M.; Kelly, J.M. New trends in photobiology. J. Photochem. Photobiol. B 1993, 21, 103-124.
35. Millson, C.E.; Wilson, M.; Macrobert, A.J.; Bedwell, J.; Bown, S.G. The killing of helicobacter pylori by low-power laser light in the presence of a photosensitiser. J. Med. Microbiol. 1996, 44, 245-252.
36. Tardivo, J.P.; del Giglio, A.; de Oliveira, C.S.; Gabrielli, D.S.; Junqueira, H.C.; Tada, D.B.; Severino, D.; de Fátima Turchiello, R.; Baptista, M.S. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagn. Photodyn. Ther. 2005, 2, 175-191.
37. Soukos, N.S.; Chen, P.S.-Y.; Morris, J.T.; Ruggiero, K.; Abernethy, A.D.; Som, S.; Foschi, F.; Doucette, S.; Luschke Bammann, L.; Fontana, C.R.; et al. Photodynamic therapy for endodontic disinfection. J. Endod. 2006, 32, 979-984.
38. De Freitas, L.M.; Soares, C.P.; Fontana, C.R. Synergistic effect of photodynamic therapy and cisplatin: A novel approach for cervical cancer. J. Photochem. Photobiol. B 2014, 140, 365-373.
39. Wagner, M.; Suarez, E.R.; Theodoro, T.R.; Machado Filho, C.D.A.S.; Gama, M.F.M.; Tardivo, J.P.; Paschoal, F.M.; Pinhal, M.A.S. Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. Clin. Exp. Dermatol. 2012, 37, 527-533.
40. Samy, N.A.; Salah, M.M.; Ali, M.F.; Sadek, A.M. Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. Laser Med. Sci. 2014, 30, 109-115.
41. Disanto, A.R.; Wagner, J.G. Pharmacokinetics of highly ionized drugs ii: Methylene blue-Absorption, metabolism, and excretion in man and dog after oral administration. J. Pharm. Sci. 1972, 61, 1086-1090.
42. Kessel, D.; Thompson, P. Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse-phase chromatography. Photochem. Photobiol. 1987, 46, 1023-1025.
43. Bonnett, R.; Grahn, M.; Salgado, A.; Turkish, M.; Valles, M.; Williams, N. Amphiphilic chlorins derived from chlorophyll a for photodynamic therapy. Photodyn. Ther. Biomed. Lasers 1992, 10, 866-869.
44. Calvete, M.J.F.; Gomes, A.T.P.; Moura, N.M. Clorinas em terapia fotodinâmica-síntese e aplicações. Rev. Virtual Quím. 2009, 1, 92-103.
45. Yano, S.; Hirohara, S.; Obata, M.; Hagiya, Y.; Ogura, S.-I.; Ikeda, A.; Kataoka, H.; Tanaka, M.; Joh, T. Current states and future views in photodynamic therapy. J. Photochem. Photobiol. C 2011, 12, 46-67.
46. Taber, S.W.; Fingar, V.H.; Coots, C.T.; Wieman, T.J. Photodynamic therapy using mono-L-aspartyl chlorin e6 (npe6) for the treatment of cutaneous disease: A phase i clinical study. Clin. Cancer Res. 1998, 4, 2741-2746.
47. Bonnett, R.; Charlesworth, P.; D. Djelal, B.; Foley, S.; J. McGarvey, D.; George Truscott, T. Photophysical properties of 5,10,15,20-tetrakis(m-hydroxyphenyl)porphyrin (m-thpp), 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-thpc) and 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-thpbc): A comparative study. J. Chem. Soc. Perkin Trans 2 1999, 325-328.
48. Correa, J.C.; Bagnato, V.S.; Imasato, H.; Perussi, J.R. Previous illumination of a water soluble chlorine photosensitizer increases its cytotoxicity. Laser Phys. 2012, 22, 1387-1394.
49. Ferreira, J.; Menezes, P.F.C.; Sibata, C.H.; Allison, R.R.; Zucoloto, S.; Castro e Silva, O.; Bagnato, V.S. Can efficiency of the photosensitizer be predicted by its photostability in solution? Laser Phys. 2009, 19, 1932-1938.
50. Parihar, A.; Dube, A.; Gupta, P.K. Conjugation of chlorin p 6 to histamine enhances its cellular uptake and phototoxicity in oral cancer cells. Cancer Chemother. Pharmacol. 2010, 68, 359-369.
51. Kobayashi, W.; Liu, Q.; Nakagawa, H.; Sakaki, H.; Teh, B.; Matsumiya, T.; Yoshida, H.; Imaizumi, T.; Satoh, K.; Kimura, H. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: Experimental study on an animal model of nude mouse. Oral Oncol. 2006, 42, 45-49.
52. Boddupalli, B.M.; Mohammed, Z.N.K.; Nath, R.A.; Banji, D. Mucoadhesive drug delivery system: An overview. J. Adv. Pharm. Technol. Res. 2010, 1, 381-387.
53. Master, A.; Livingston, M.; Sen Gupta, A. Photodynamic nanomedicine in the treatment of solid tumors: Perspectives and challenges. J. Control. Release 2013, 168, 88-102.
54. Aggarwal, B.B.; Sundaram, C.; Malani, N.; Ichikawa, H. Curcumin: The Indian solid gold. In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease; Aggarwal, B.B., Surh, Y.-J., Shishodia, S., eds.; Springer: Boston, MA, USA, 2007; pp. 1-75.
55. Lee, W.-H.; Loo, C.-Y.; Bebawy, M.; Luk, F.; Mason, R.S.; Rohanizadeh, R. Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Curr. Neuropharmacol. 2013, 11, 338-378.
56. Haukvik, T.; Bruzell, E.; Kristensen, S.; Tønnesen, H.H. Photokilling of bacteria by curcumin in selected polyethylene glycol 400 (peg 400) preparations. Studies on curcumin and curcuminoids, xli. Pharmazie 2010, 65, 600-606.
57. LoTempio, M.M.; Veena, M.S.; Steele, H.L.; Ramamurthy, B.; Ramalingam, T.S.; Cohen, A.N.; Chakrabarti, R.; Srivatsan, E.S.; Wang, M.B. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin. Cancer Res. 2005, 11, 6994-7002.
58. Fodor, L.; Elman, M.; Ullmann, Y. Aesthetic Applications of Intense Pulsed Light; Springer Science & Business Media: New York, NY, USA, 2010.
59. Murali Mohan, Y.; Mitch Ray, D.; Diane Michele, M.; Meena, J.; Subhash Chand, C. Design of curcumin loaded cellulose nanoparticles for prostate cancer. Curr. Drug Metab. 2012, 13, 120-128.
60. Allen, C.M.; Sharman, W.M.; van Lier, J.E. Current status of phthalocyanines in the photodynamic therapy of cancer. J. Porphyr. Phthalocyanines 2001, 5, 161-169.
61. Ranyuk, E.; Cauchon, N.; Klarskov, K.; Guérin, B.; van Lier, J.E. Phthalocyanine-peptide conjugates: Receptor-targeting bifunctional agents for imaging and photodynamic therapy. J. Med. Chem. 2013, 56, 1520-1534.
62. Swavey, S.; Tran, M. Porphyrin and phthalocyanine photosensitizers as pdt agents: A new modality for the treatment of melanoma. In Recent Advances in the Biology, Therapy and Management of Melanoma; Davids, L.M., Ed.; INTECH Open Access Publisher: Rijeka, Croatia, 2013; pp. 253-282.
63. Muehlmann, L.A.; Ma, B.C.; Longo, J.P.F.; Almeida Santos, M.d.F.M.; Azevedo, R.B. Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. Int. J. Nanomed. 2014, 9, 1199-1213.
64. Zasedatelev, A.V.; Dubinina, T.V.; Krichevsky, D.M.; Krasovskii, V.I.; Gak, V.Y.; Pushkarev, V.E.; Tomilova, L.G.; Chistyakov, A.A. Plasmon-induced light absorption of phthalocyanine layer in hybrid nanoparticles: Enhancement factor and effective spectra. J. Phys. Chem. C 2016, 120, 1816-1823.
65. Nombona, N.; Antunes, E.; Chidawanyika, W.; Kleyi, P.; Tshentu, Z.; Nyokong, T. Synthesis, photophysics and photochemistry of phthalocyanine-ϵ-polylysine conjugates in the presence of metal nanoparticles against staphylococcus aureus. J. Photochem. Photobiol. A 2012, 233, 24-33.
66. Kleemann, B.; Loos, B.; Scriba, T.J.; Lang, D.; Davids, L.M. St John's wort (hypericum perforatum l.) photomedicine: Hypericin-photodynamic therapy induces metastatic melanoma cell death. PLoS ONE 2014, 9, e103762.
67. Maduray, K.; Davids, L. The anticancer activity of hypericin in photodynamic therapy. J. Bioanal. Biomed. 2012, 2012.
68. Kubin, A.; Wierrani, F.; Burner, U.; Alth, G.; Grunberger, W. Hypericin-The facts about a controversial agent. Curr. Pharm. Des. 2005, 11, 233-253.
69. Barathan, M.; Mariappan, V.; Shankar, E.M.; Abdullah, B.J.; Goh, K.L.; Vadivelu, J. Hypericin-photodynamic therapy leads to interleukin-6 secretion by hepg2 cells and their apoptosis via recruitment of bh3 interacting-domain death agonist and caspases. Cell Death Dis. 2013, 4.
70. Guedes, R.C.; Eriksson, L.A. Theoretical study of hypericin. J. Photochem. Photobiol. A 2005, 172, 293-299.
71. Dets, S.M.; Buryi, A.N.; Melnik, I.S.; Joffe, A.Y.; Rusina, T.V. Laser-Induced Fluorescence Detection of Stomach Cancer Using Hypericin; Optical Biopsies and Microscopic Techniques: Vienna, Austria; The International Society for Optical Engineering, SPIE: Vienna, Austria, 1996; pp. 51-56.
72. Agostinis, P.; Vantieghem, A.; Merlevede, W.; de Witte, P.A.M. Hypericin in cancer treatment: More light on the way. Int. J. Biochem. Cell Biol. 2002, 34, 221-241.
73. Konan, Y.N.; Gurny, R.; Allémann, E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 2002, 66, 89-106.
74. Roozeboom, M.H.; Aardoom, M.A.; Nelemans, P.J.; Thissen, M.R.T.M.; Kelleners-Smeets, N.W.J.; Kuijpers, D.I.M.; Mosterd, K. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up. J. Am. Acad. Dermatol. 2013, 69, 280-287.
75. Lima, A.M.; Pizzol, C.D.; Monteiro, F.B.F.; Creczynski-Pasa, T.B.; Andrade, G.P.; Ribeiro, A.O.; Perussi, J.R. Hypericin encapsulated in solid lipid nanoparticles: Phototoxicity and photodynamic efficiency. J. Photochem. Photobiol. B 2013, 125, 146-154.
76. Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16-20.
77. Calixto, G.; Bernegossi, J.; Fonseca-Santos, B.; Chorilli, M. Nanotechnology-based drug delivery systems for treatment of oral cancer: A review. Int. J. Nanomed. 2014, 9, 3719-3735.
78. Bernegossi, J.; Calixto, G.; Santos, B.F.; Aida, K.L.; Negrini, T.C.; Duque, C.; Gremião, M.P.D.; Chorilli, M. Highlights in peptide nanoparticle carriers intended to oral diseases. Curr. Top. Med. Chem. 2015, 15, 345-355.
79. Manmode, A.S.; Sakarkar, D.M.; Mahajan, N.M. Nanoparticles-tremendous therapeutic potential: A review. Int. J. PharmTech Res. 2009, 1, 1020-1027.
80. Ohulchanskyy, T.Y.; Roy, I.; Goswami, L.N.; Chen, Y.; Bergey, E.J.; Pandey, R.K.; Oseroff, A.R.; Prasad, P.N. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett. 2007, 7, 2835-2842.
81. Khdair, A.; Gerard, B.; Handa, H.; Mao, G.; Shekhar, M.P.V.; Panyam, J. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Mol. Pharm. 2008, 5, 795-807.
82. Yu, Z.; Li, H.; Zhang, L.-M.; Zhu, Z.; Yang, L. Enhancement of phototoxicity against human pancreatic cancer cells with photosensitizer-encapsulated amphiphilic sodium alginate derivative nanoparticles. Int. J. Pharm. 2014, 473, 501-509.
83. Yuan, Y.; Liu, B. Self-Assembled Nanoparticles Based on PEGylated Conjugated Polyelectrolyte and Drug Molecules for Image-Guided Drug Delivery and Photodynamic Therapy. ACS Appl. Mater. Inter. 2014, 6, 14903-14910.
84. Jin, S.; Zhou, L.; Gu, Z.; Tian, G.; Yan, L.; Ren, W.; Yin, W.; Liu, X.; Zhang, X.; Hu, Z.; et al. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin a for photodynamic therapy of cancer cells. Nanoscale 2013, 5, 11910-11918.
85. El-Daly, S.M.; Gamal-Eldeen, A.M.; Abo-Zeid, M.A.; Borai, I.H.; Wafay, H.A.; Abdel-Ghaffar, A.R.B. Photodynamic therapeutic activity of indocyanine green entrapped in polymeric nanoparticles. Photodiagn. Photodyn. Ther. 2013, 10, 173-185.
86. Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (sln) for controlled drug delivery - A review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50, 161-177.
87. Youssef, T.; Fadel, M.; Fahmy, R.; Kassab, K. Evaluation of hypericin-loaded solid lipid nanoparticles: Physicochemical properties, photostability and phototoxicity. Pharm. Dev. Technol. 2012, 17, 177-186.
88. Duncan, B.; Kim, C.; Rotello, V.M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J. Control. Release 2010, 148, 122-127.
89. Shi, J.; Yu, X.; Wang, L.; Liu, Y.; Gao, J.; Zhang, J.; Ma, R.; Liu, R.; Zhang, Z. Pegylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and mr imaging. Biomaterials 2013, 34, 9666-9677.
90. Andrade, C.A.S.; Correia, M.T.S.; Coelho, L.C.B.B.; Nascimento, S.C.; Santos-Magalhães, N.S. Antitumor activity of cratylia mollis lectin encapsulated into liposomes. Int. J. Pharm. 2004, 278, 435-445.
91. Chorilli, M.; Calixto, G.; Rimério, T.C.; Scarpa, M.V. Caffeine encapsulated in small unilamellar liposomes: Characerization and in vitro release profile. J. Dispers. Sci. Technol. 2013, 34, 1465-1470.
92. Bovis, M.J.; Woodhams, J.H.; Loizidou, M.; Scheglmann, D.; Bown, S.G.; MacRobert, A.J. Improved in vivo delivery of m-thpc via pegylated liposomes for use in photodynamic therapy. J. Control. Release 2012, 157, 196-205.
93. Derycke, A.S.; Kamuhabwa, A.; Gijsens, A.; Roskams, T.; de Vos, D.; Kasran, A.; Huwyler, J.; Missiaen, L.; de Witte, P.A. Transferrin-conjugated liposome targeting of photosensitizer alpcs4 to rat bladder carcinoma cells. J. Natl. Cancer Inst. 2004, 96, 1620-1630.
94. Takeuchi, Y.; Kurohane, K.; Ichikawa, K.; Yonezawa, S.; Nango, M.; Oku, N. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Cancer 2003, 97, 2027-2034.
95. Pierre, M.B.R.; Tedesco, A.C.; Marchetti, J.M.; Bentley, M.V.L. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: Preparation and in vitro permeation study. BMC Dermatol. 2001, 1.
96. Nombona, N.; Maduray, K.; Antunes, E.; Karsten, A.; Nyokong, T. Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy. J. Photochem. Photobiol. B 2012, 107, 35-44.
97. Barbugli, P.A.; Alves, C.P.; Espreafico, E.M.; Tedesco, A.C. Photodynamic therapy utilizing liposomal clalpc in human melanoma 3d cell cultures. Exp. Dermatol. 2015, 24, 970-972.
98. Eldin, M.S.M.; Kamoun, E.A.; Sofan, M.A.; Elbayomi, S.M. L-arginine grafted alginate hydrogel beads: A novel ph-sensitive system for specific protein delivery. Arab. J. Chem. 2015, 8, 355-365.
99. Lyra, M.A.M.d.; Soares-Sobrinho, J.L.; Brasileiro, M.T.; De la Roca, M.F.; Barraza, J.A.; Viana, O.d.S.; Rolim Neto, P.J. Sistemas matriciais hidrofílicos e mucoadesivos para liberação controlada de fármacos. Lat. Am. J. Pharm. 2007, 26, 784-793.
100. Barcellos, I.O.; Katime, I.A.; Soldi, V.; Pires, A.T.N. Influência do comonômero e do método de polimerização na cinética de liberação de fenobarbitona a partir de hidrogéis. Polímeros 2000, 10, 110-115.
101. Mori, K.; Yoneya, S.; Anzail, K.; Kabasawa, S.; Sodeyama, T.; Peyman, G.A.; Moshfeghi, D.M. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: Mono-l-aspartyl chlorin e6. Retina 2001, 21, 499-508.
102. Kim, J.; Kim, K.S.; Park, S.-J.; Na, K. Vitamin bc-bearing hydrophilic photosensitizer conjugate for photodynamic cancer theranostics. Macromol. Biosci. 2015, 15, 1081-1090.
103. Noiseux, I.; Mermut, O.; Bouchard, J.-P.; Cormier, J.-F.; Desroches, P.; Fortin, M.; Gallant, P.; Leclair, S.; Vernon, M.L.; Diamond, K.R.; et al. Effect of liposomal confinement on photochemical properties of photosensitizers with varying hydrophilicity. J. Biomed. Opt. 2008, 13.
104. Reza Saboktakin, M.; Tabatabaie, R.M.; Maharramov, A.; Ali Ramazanov, M. Synthesis and in vitro studies of biodegradable modified chitosan nanoparticles for photodynamic treatment of cancer. Int. J. Biol. Macromol. 2011, 49, 1059-1065.
105. Jin, H.; Dai, X.-H.; Wu, C.; Pan, J.-M.; Wang, X.-H.; Yan, Y.-S.; Liu, D.-M.; Sun, L. Rational design of shear-thinning supramolecular hydrogels with porphyrin for controlled chemotherapeutics release and photodynamic therapy. Eur. Polym. J. 2015, 66, 149-159.
106. Gosenca, M.; Bešter-Rogač, M.; Gašperlin, M. Lecithin based lamellar liquid crystals as a physiologically acceptable dermal delivery system for ascorbyl palmitate. Eur. J. Pharm. Sci. 2013, 50, 114-122.
107. Chorilli, M.; Prestes, P.S.; Rigon, R.B.; Leonardi, G.R.; Chiavacci, L.A.; Scarpa, M.V. Development of liquid-crystalline systems using silicon glycol copolymer and polyether functional siloxane. Quim. Nova 2009, 32, 1036-1040.
108. Guo, C.; Wang, J.; Cao, F.; Lee, R.J.; Zhai, G. Lyotropic liquid crystal systems in drug delivery. Drug Discov. Today 2010, 15, 1032-1040.
109. Ghosh, O.; Miller, C.A. Lamellar liquid crystals in equilibrium with excess oil in anionic surfactant-oil-brine systems. J. Colloid Interface Sci. 1987, 116, 593-597.
110. Garti, N.; Hoshen, G.; Aserin, A. Lipolysis and structure controlled drug release from reversed hexagonal mesophase. Colloids Surf. B 2012, 94, 36-43.
111. Lopes, L.B.; Ferreira, D.A.; Paula, D.; Garcia, M.T.J.; Thomazini, J.A.; Fantini, M.C.A.; Bentley, M.V.L.B. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: In vitro and in vivo skin penetration of cyclosporin a. Pharm. Res. 2006, 23, 1332-1342.
112. Rossetti, F.C.; Depieri, L.V.; Praça, F.G.; del Ciampo, J.O.; Fantini, M.C.A.; Pierre, M.B.R.; Tedesco, A.C.; Bentley, M.V.L.B. Optimization of protoporphyrin ix skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. Eur. J. Pharm. Sci. 2016, 83, 99-108.
113. Tomalia, D.A.; Khanna, S.N. A systematic framework and nanoperiodic concept for unifying nanoscience: Hard/soft nanoelements, superatoms, meta-atoms, new emerging properties, periodic property patterns, and predictive mendeleev-like nanoperiodic tables. Chem. Rev. 2016, 116, 2705-2774.
114. Caminade, A.-M.; Turrin, C.-O.; Majoral, J.-P. Biological properties of water-soluble phosphorhydrazone dendrimers. Braz. J. Pharm. Sci. 2013, 49, 33-44.
115. Narsireddy, A.; Vijayashree, K.; Adimoolam, M.G.; Manorama, S.V.; Rao, N.M. Photosensitizer and peptide-conjugated pamam dendrimer for targeted in vivo photodynamic therapy. Int. J. Nanomed. 2015, 10, 6865-6878.
116. Rodriguez, L.; Vallecorsa, P.; Battah, S.; Di Venosa, G.; Calvo, G.; Mamone, L.; Saenz, D.; Gonzalez, M.C.; Batlle, A.; MacRobert, A.J.; et al. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease. Photochem. Photobiol. Sci. 2015, 14, 1617-1627.
117. Kojima, C.; Toi, Y.; Harada, A.; Kono, K. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjugate Chem. 2007, 18, 663-670.
118. Nishiyama, N.; Jang, W.-D.; Kataoka, K. Supramolecular nanocarriers integrated with dendrimers encapsulating photosensitizers for effective photodynamic therapy and photochemical gene delivery. New J. Chem. 2007, 31, 1074-1082.
119. Karthikeyan, K.; Babu, A.; Kim, S.-J.; Murugesan, R.; Jeyasubramanian, K. Enhanced photodynamic efficacy and efficient delivery of rose bengal using nanostructured poly(amidoamine) dendrimers: Potential application in photodynamic therapy of cancer. Cancer Nanotechnol. 2011, 2, 95-103.
120. Venturini, C.d.G.; Nicolini, J.; Machado, C.; Machado, V.G. Properties and recent applications of cyclodextrins. Quim. Nova 2008, 31, 360-368.
121. Saltão, R.; Veiga, F. Ciclodextrinas em novos sistemas terapêuticos. Braz. J. Pharm. Sci. 2001, 37, 1-17.
122. Conte, C.; Scala, A.; Siracusano, G.; Leone, N.; Patane, S.; Ungaro, F.; Miro, A.; Sciortino, M.T.; Quaglia, F.; Mazzaglia, A. Nanoassembly of an amphiphilic cyclodextrin and Zn(II)-phthalocyanine with the potential for photodynamic therapy of cancer. RSC Adv. 2014, 4, 43903-43911.
123. Lourenco, L.M.O.; Pereira, P.M.R.; Maciel, E.; Valega, M.; Domingues, F.M.J.; Domingues, M.R.M.; Neves, M.G.P.M.S.; Cavaleiro, J.A.S.; Fernandes, R.; Tome, J.P.C. Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy. Chem. Commun. 2014, 50, 8363-8366.